Get started
Author

Mohamed K. Elgohary

Observed names: Elgohary, Mohamed K., Mohamed Elgohary
Observed institution: Egyptian Russian University
ORCID: 0000-0002-8269-9526
Observed ORCID: 0000-0002-8269-9526
OpenAlex ID: A5012804790
Novel imidazo[2,1-b]thiazoles and imidazo[1,2-a]pyridines tethered with indolinone motif as VEGFR-2 inhibitors and apoptotic inducers: Design, synthesis and biological evaluations
2024 · Mahmoud S. Elkotamy, Mohamed K. Elgohary, et al. · Bioorganic Chemistry · 64
Design, synthesis, and evaluation of novel benzofuran and pyrazole-based derivatives as dual AChE/BuChE inhibitors with antioxidant properties for Alzheimer's disease management
2024 · Mahmoud S. Elkotamy, Mohamed K. Elgohary, et al. · European Journal of Medicinal Chemistry · 33
Fragment merging approach for the design of thiazole/thiazolidine clubbed pyrazoline derivatives as anti-inflammatory agents: Synthesis, biopharmacological evaluation and molecular modeling studies
2023 · Mohamed K. Elgohary, Soha R. Abd El Hadi, et al. · Bioorganic Chemistry · 29
Fenamates and ibuprofen as foundational components in the synthesis of innovative, targeted COX-2 anti-inflammatory drugs, undergoing thorough biopharmacological assessments and in-silico computational studies
2024 · Mohamed K. Elgohary, Mahmoud S. Elkotamy, et al. · Bioorganic Chemistry · 26
Design, Synthesis and Biological Assessment of N′-(2-Oxoindolin-3-ylidene)-6-methylimidazo[2,1-b]thiazole-5-carbohydrazides as Potential Anti-Proliferative Agents toward MCF-7 Breast Cancer
2024 · Najla A. Alshaye, Mohamed K. Elgohary, et al. · Pharmaceuticals · 22
PDF
Sulfonamide-Pyrazole derivatives as next-generation Cyclooxygenase-2 enzyme inhibitors: From molecular design to in vivo efficacy
2024 · Mohamed K. Elgohary, Mahmoud S. Elkotamy, et al. · International Journal of Biological Macromolecules · 21
Exploring antitumor activity of novel imidazo[2,1-b]thiazole and imidazo[1,2-a]pyridine derivatives on MDA-MB-231 cell line: Targeting VEGFR-2 enzyme with computational insight
2024 · Mohamed K. Elgohary, Mahmoud S. Elkotamy, et al. · Journal of Molecular Structure · 20
Design, synthesis, and molecular dynamics-driven evaluation of quinoline-sulfonamide derivatives as potent and selective EGFR inhibitors with promising anti-cancer efficacy and safety profiles
2025 · Mahmoud S. Elkotamy, Mohamed K. Elgohary, et al. · Bioorganic Chemistry · 19
Development of new LSM-83177 analogues as anti-tumor agents against colorectal cancer targeting p53-MDM2 interaction
2024 · Mohamed K. Elgohary, Mahmoud S. Elkotamy, et al. · Bioorganic Chemistry · 18
Design, synthesis and biological evaluation of pyrazolo[3,4- b ]pyridine derivatives as dual CDK2/PIM1 inhibitors with potent anti-cancer activity and selectivity
2025 · Mahmoud S. Elkotamy, Mohamed K. Elgohary, et al. · Journal of Biomolecular Structure and Dynamics · 17
Novel anti-inflammatory agents featuring phenoxy acetic acid moiety as a pharmacophore for selective COX-2 inhibitors: Synthesis, biological evaluation, histopathological examination and molecular modeling investigation
2024 · Mohamed K. Elgohary, Mahmoud F. Abo-Ashour, et al. · Bioorganic Chemistry · 17
Design, Synthesis, and Biological Evaluation of Novel Phenoxy Acetic Acid Derivatives as Selective COX-2 Inhibitors Coupled with Comprehensive Bio-Pharmacological Inquiry, Histopathological Profiling, and Toxicological Scrutiny
2024 · Najla A. Alshaye, Mohamed K. Elgohary, et al. · Molecules · 16
PDF
Molecular docking, DFT and antiproliferative properties of 4‐(3,4‐dimethoxyphenyl)−3‐(4‐methoxyphenyl)−1‐phenyl‐1H‐pyrazolo[3,4‐b]pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potency
2024 · Faizah A. Binjubair, Basma S. Almansour, et al. · Drug Development Research · 14
PDF
Spiro-fused indoline-quinazoline hybrids as smart bombs against TNF-α-mediated inflammation
2024 · Mahmoud S. Elkotamy, Mohamed K. Elgohary, et al. · International Journal of Biological Macromolecules · 13
Development of Benzothiazole-grafted Pyrazolo[1,5-a]pyrimidines as new CDK2 inhibitors and anti-prostate cancer agents
2025 · Mahmoud S. Elkotamy, Mohamed K. Elgohary, et al. · Bioorganic Chemistry · 11
Rational Design of Triazole Hydrazide Derivatives With Imidazo[2,1‐ b ]thiazole Scaffolds as Targeted EGFR Inhibitors in NSCLC
2025 · Mohamed K. Elgohary, Mahmoud S. Elkotamy, et al. · Drug Development Research · 9
Discovering new CDK2 inhibitors by molecular docking and drug-likeness-based virtual screening for potential anticancer uses.
2024 · Mahmoud Elkotamy, Mohamed Elgohary, et al. · ERU Research Journal · 8
Discovery and characterization of phenoxyacetic acid derivatives as potential antiepileptic agents
2025 · Mohamed K. Elgohary, Mahmoud S. Elkotamy, et al. · RSC Advances · 6
PDF
Pyrazole–triazole hybrids as kinase-triad inhibitors: a triple-target strategy for synergistic anticancer therapy
2026 · Mahmoud S. Elkotamy, Mohamed K. Elgohary, et al. · RSC Medicinal Chemistry · 5
Harnessing benzofuran scaffolds: A journey through design, synthesis, and biological discovery toward safer anti-diabetic and anti-oxidant candidates
2025 · Mohamed K. Elgohary, Mahmoud S. Elkotamy, et al. · European Journal of Medicinal Chemistry · 4
Design and evaluation of 2-(4-((2-(2-((2,6-dichloro-3-methylphenyl)amino)benzoyl)hydrazineylidene)methyl)phenoxy)acetic acid as a dual anti-inflammatory and anti-diabetic agent
2025 · Mohamed K. Elgohary, Mahmoud S. Elkotamy, et al. · Future Medicinal Chemistry · 3
PDF
Structure-guided design and synthesis of Etoricoxib analogues for selective COX-2 inhibition: in vitro assessment and computational insights with prospective in vivo confirmation
2026 · Mohammed H. Alqarni, Mohamed K. Elgohary, et al. · Molecular Diversity · 2
Phenoxyacetic acid scaffold as a platform for dual anticonvulsant and anti-inflammatory drug design
2026 · Mohamed K. Elgohary, Mahmoud Abdelrahman Alkabbani, et al. · RSC Medicinal Chemistry · 2
Unlocking the antidiabetic potential of novel pyrazole-triazole hybrids through synthesis, dual α-amylase/α-glucosidase inhibition, multiscale biological evaluation, and molecular dynamics studies
2026 · Mariam M. Fakhry, Mahmoud S. Elkotamy, et al. · RSC Advances · 2
Development of Phenoxyacetic Acid Hybrids With COX‐2 Inhibitory Activity as Potential Anti‐Neuroinflammatory Agents
2026 · Mohammad H. Alqarni, Mahmoud Abdelrahman Alkabbani, et al. · Drug Development Research
PDF
Works count: 31
Citation count: 381
H-index: 13
I10-index: 15
Year
Topic
Type